Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC‐3 human prostate cancer cells

Authors:
  • YSYan-Sheng Su
    Yan-Sheng Su
  • JZJie Zhao
    Jie Zhao
  • HWHe Wang
    He Wang
  • WLWei Li
    Wei Li

Abstract
Epigenetic silencing mechanisms play an important role in chemoresistance of human cancer. Here we report the upregulated expression of metastasis‐associated protein 1 (MTA1), a component of the nucleosome remodeling deacetylation (NuRD) complex, in chemoresistant prostate cancer (PCa). MTA1 knockdown in PC‐3 cells inhibited cell proliferation and enhanced docetaxel (DTX)‐induced cell death. Conversely, overexpression of MTA1 promotes DTX chemoresistance in PC‐3 cells. MTA1 acted as a potent corepressor of the nuclear receptor NR4A1 transcription by interacting with histone deacetylase 2 (HDAC2). These findings suggest that MTA1 may serve as a novel DTX‐resistance promoter in PC‐3 cells.
Funding Information
  • Natural Science Foundation of China (31271248)

This publication has 39 references indexed in Scilit: